Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication
Published on: August 16, 2024
Harnessing the power of bioprinting for the development of next-generation models of thrombosis
Yanyan Liu1, Tao Huang1,2, Nicole Alexis Yap1
1School of Biomedical Engineering, The University of Sydney, Darlington, NSW, 2008, Australia.
Insights
Bioprinting creates advanced vascular models to study thrombosis, overcoming limitations of current research systems. These biomimetic models improve understanding of blood clot formation for better cardiovascular disease treatments.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Regenerative Medicine
Background:
- Thrombosis is a major cause of cardiovascular disease, but current research models inadequately mimic human vascular complexity and hemodynamics.
- Limitations in existing animal and in vitro models hinder a comprehensive understanding of thrombosis mechanisms.
- Bioprinting offers a novel approach to engineer biomimetic vascular conduits for more accurate thrombosis studies.
Purpose of the Study:
- To review key considerations in designing bioprinted vascular conduits for thrombosis research.
- To highlight advancements in bioprinting techniques for creating physiologically relevant thrombosis models.
- To discuss future directions and challenges in bioprinted vascular models for thrombosis.
Main Methods:
- Review of current literature on bioprinting techniques for vascular tissue engineering.
- Analysis of essential structural, biochemical, and mechanical features for biomimetic vascular models.
- Discussion of biomaterial selection and cell sourcing strategies for bioprinted vascular conduits.
Main Results:
- Bioprinting enables the creation of vascular models with properties mimicking native blood vessels.
- Advanced techniques like multi-material bioprinting and microfluidic integration yield physiologically relevant thrombosis models.
- Bioprinted models show promise in overcoming limitations of traditional research systems.
Conclusions:
- Bioprinted vascular models represent a significant advancement in thrombosis research, offering superior biomimicry.
- Future developments integrating patient-specific data and real-time monitoring will enhance personalized medicine approaches.
- Continued innovation in bioprinting is crucial for unraveling thrombosis complexities and improving patient outcomes.
Abstract:
Thrombosis, a leading cause of cardiovascular morbidity and mortality, involves the formation of blood clots within blood vessels. Current animal models and in vitro systems have limitations in recapitulating the complex human vasculature and hemodynamic conditions, limiting the research in understanding the mechanisms of thrombosis. Bioprinting has emerged as a promising approach to construct biomimetic vascular models that closely mimic the structural and mechanical properties of native blood vessels. This review discusses the key considerations for designing bioprinted vascular conduits for thrombosis studies, including the incorporation of key structural, biochemical and mechanical features, the selection of appropriate biomaterials and cell sources, and the challenges and future directions in the field. The advancements in bioprinting techniques, such as multi-material bioprinting and microfluidic integration, have enabled the development of physiologically relevant models of thrombosis. The future of bioprinted models of thrombosis lies in the integration of patient-specific data, real-time monitoring technologies, and advanced microfluidic platforms, paving the way for personalized medicine and targeted interventions. As the field of bioprinting continues to evolve, these advanced vascular models are expected to play an increasingly important role in unraveling the complexities of thrombosis and improving patient outcomes. The continued advancements in bioprinting technologies and the collaboration between researchers from various disciplines hold great promise for revolutionizing the field of thrombosis research.

